Salute e Benessere
Esaote Group to Showcase Cardiac Innovation at ESC 2025 in Madrid
Among the highlights will be the launch of the , a powerful portable ultrasound system engineered specifically for cardiology. With the largest-in-class touchscreen, an intuitive touch interface, and , the MyLab™C30 cardio significantly while ensuring diagnostic confidence—even in the most complex cases, by providing reliable qualitative and quantitative assessments. Its extended battery life and robust performance make it ideal for both routine and emergency settings.
Also being introduced is , a It is designed to empower healthcare professionals with the acquisition of transthoracic cardiac ultrasound images by providing real-time AI feedback on view classification and image quality. This accelerates daily practice for all cardiologists, particularly benefiting emergency care settings and less experienced professionals.
An insightful presentation on and their clinical applications will be held to assess how force distribution analysis can identify dilated or dysfunctional hearts and monitor the impact of resynchronization therapies in heart failure patients.
On the healthcare IT front, , the Healthcare IT company of Esaote, will showcase the latest evolution of its . Designed for both ambulatory and interventional cardiology, the platform integrates AI-powered tools such as for clinical decision support and for intelligent workflow orchestration. It also offers seamless integration with advanced tools like
is developed by (part of the Esaote Group). The upcoming version
introduces , designed
for standardized measurements, and
spent navigating through image sets. Furthermore, . CAAS Qardia enables both standalone and zero-footprint access via web browser.
reaffirms its commitment to advancing cardiovascular diagnostics through innovation, clinical collaboration, and ongoing R&D investment.
is a leader in medical imaging (ultrasound, MRI and diagnostic process management software). At the end of 2024, the Group had 1,300 employees, half of which are based in Italy . With facilities in Genoa and Florence and its own production and research units in Italy and the Netherlands , Esaote is present in over 100 countries worldwide. www.esaote.com
Logo - https://mma.prnewswire.com/media/2327879/Esaote_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/esaote-group-to-showcase-cardiac-innovation-at-esc-2025-in-madrid-302539419.html